Marketing-authorisation holder

Sun Pharma Canada Inc

208 medicines2 countries

208 medicines in 2 countries, as authorisation holder.

Medicines

Every medicine in the registers under its name, current ones first.

1–25 of 208

Medicine	Substance	Country	Status	Authorised
ADAPALENE AND BENZOYL PEROXIDE0.1%; 2.5% \| 0.3%; 2.5% · GEL	Adapalene, Benzoyl peroxide	United States	Marketed	2015
ALCLOMETASONE DIPROPIONATE0.05% · Ointment	Alclometasone	United States	Marketed	2004
ALCLOMETASONE DIPROPIONATE0.05% · Cream	Alclometasone	United States	Marketed	2005
AMMONIUM LACTATE12% base · Cream	Ammonium	United States	Marketed	2002
AZELAIC ACID15% · GEL	Azelaic acid	United States	Marketed	2018
BETAMETHASONE DIPROPIONATE0.05% base · Gel, augmented	Betamethasone	United States	Marketed	2003
BETAMETHASONE DIPROPIONATE0.05% base · Lotion, augmented	Betamethasone	United States	Marketed	2007
BETAMETHASONE DIPROPIONATE0.05% base/spray · Spray	Betamethasone	United States	Not marketed	2020
BUTENAFINE HYDROCHLORIDE1% · Cream	Butenafine	United States	Marketed	2017
CICLOPIROX1% · Shampoo	Ciclopirox	United States	Marketed	2009
CLINDAMYCIN PHOSPHATE1% base · GEL	Clindamycin	United States	Marketed	2000
CLINDAMYCIN PHOSPHATE1% base · Lotion	Clindamycin	United States	Marketed	2002
CLOBETASOL PROPIONATE0.05% · GEL	Clobetasol	United States	Marketed	1997
CLOTRIMAZOLE1% · Cream	Clotrimazole	United States	Marketed	1993
CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE0.05% base; 1% · Lotion	Betamethasone, Clotrimazole	United States	Marketed	2004
DERMABET0.1% base · Cream	Betamethasone	United States	Marketed	1988
DIFLORASONE DIACETATE0.05% · Cream	Diflorasone	United States	Marketed	1998
DOMPERIDONE10 mg · Tablet	Domperidone	Canada	Authorised
DOXEPIN HYDROCHLORIDE5% · Cream	Doxepin	United States	Marketed	2023
FLO-PRED15mg base/5ml \| 5mg base/5ml · Suspension	Prednisolone	United States	Not marketed	2008
FLUOCINONIDE0.05% \| 0.05% Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons \| 0.1% · Cream	Fluocinonide	United States	Marketed	1984
FLUOCINONIDE0.05% · Ointment	Fluocinonide	United States	Marketed	1991
HALOBETASOL PROPIONATE0.05% · Cream	Ulobetasol	United States	Marketed	2004
HALOBETASOL PROPIONATE AND TAZAROTENE0.01%; 0.045% · Lotion	Ulobetasol, Tazarotene	United States	Marketed	2025
IBUPROFEN PLUS ACETAMINOPHEN250 mg + 125 mg · Tablet	Paracetamol, Ibuprofen	Canada	Authorised

Countries

Where it holds or makes medicines, with how many are current.

Country	Medicines	Current	Past	Companies
Canada	169	158	11	Companies All medicines
United States	39	39	0	Companies All medicines

Therapeutic areas

The ATC groups most of its medicines belong to, largest first.

Lipid-modifying agentsCardiovascular system · ATC C10A
Agents acting on the renin–angiotensin systemCardiovascular system · ATC C09A
Agents acting on the renin–angiotensin systemCardiovascular system · ATC C09C
Drugs for acid-related disordersAlimentary tract and metabolism · ATC A02B
PsycholepticsNervous system · ATC N05A

Top substances

The active substances in most of its medicines.

Names in the registers

How the registers spell it, normalised: legal forms, accents and capitals removed.

sun pharma canada

Sources and licences

Compiled by Prognia from the public medicine and company registers below. Logos are not used.

U.S. Food and Drug Administration (Drugs@FDA, openFDA)

Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.

Licence: Public domain (U.S. Government work)

Health Canada, Canada

Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.

Licence: Open Government Licence Canada

Health Canada, Canada

Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.